Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159 Meeting Abstract

  


Authors: Reuss, J.; Leung, C. H.; Rosner, S.; Zhou, N.; Weissferdt, A.; Pataer, A.; Nassib William, W. Jr; Taube, J.; Broderick, S.; Spicer, J. D.; Jones, D. R.; Gibbons, D.; Heymach, J. V.; Anagnostou, V.; Lin, H.; Lee, J. J.; Sepesi, B.; Chaft, J.; Forde, P. M.; Cascone, T.
Abstract Title: Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S776
End Page: S777
Language: English
ACCESSION: WOS:001326612901512
DOI: 10.1016/j.annonc.2024.08.1268
PROVIDER: wos
Notes: Meeting Abstract: 1209MO -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Jamie Erin Chaft
    289 Chaft
  2. David Randolph Jones
    417 Jones
Related MSK Work